Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Mar 20;184(5):543-9.
doi: 10.1503/cmaj.110493. Epub 2011 Nov 7.

Canada's laws on pharmaceutical intellectual property: the case for fundamental reform

Paul Grootendorst  1 , Ron Bouchard, Aidan Hollis
Affiliations

Canada's laws on pharmaceutical intellectual property: the case for fundamental reform

Paul Grootendorst et al. CMAJ. .
No abstract available

PubMed Disclaimer

Figures

Figure 1:
Figure 1:
Number of federal court cases in which a generic drug firm was either an applicant or a respondent, 1970–2010. The line represents the introduction of Notice of Complience regulations in 1993. Source: court index and docket of federal court and federal court of appeal (http://cas-ncr-nter03.cas-satj.gc.ca/IndexingQueries/infp_queries_e.php).
See this image and copyright information in PMC

References

    1. Brander JA. Presidential address: Innovation in retrospect and prospect. Can J Econ 2010;43:1087–121
    1. Paul SM, Mytelka DS, Dunwiddie CT, et al. How to improve R&D productivity: the pharmaceutical industry’s grand challenge. Nat Rev Drug Discov 2010;9:203–14 - PubMed
    1. Boldrin M, Levine DK. Against intellectual monopoly. Cambridge (UK): Cambridge University Press; 2008
    1. Bessen J, Meurer MJ. Patent failure: how judges, bureaucrats, and lawyers put innovators at risk. Princeton (NJ): Princeton University Press; 2008
    1. Grootendorst P, Hollis A, Levine D, et al. New approaches to rewarding pharmaceutical innovation. CMAJ 2011;183:681–5 - PMC - PubMed

MeSH terms